{{companyName}} issues dividends to shareholders from excess cash {{companyName}} generates. Most companies pay dividends on a quarterly basis, but dividends may also be paid monthly, annually or at irregular intervals

Simulations Plus Stock Dividends | NASDAQ:SLP | Benzinga

Simulations Plus

Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

Macro,View,Of,Stacks,Of,Gold,Bars

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

LUCY

MSPR

SPLP

ULCC

Gold Gains Over 2%; US Consumer Sentiment Dips In April

Financial,Expert,Reviews,Market,Projections,And,Investment,Strategies,On,Computer

Analyst Color

Biotech

Government

Large Cap

Regulations

Health Care

Analyst Ratings

Movers

General

CERT

FDA introduces a new roadmap to reduce animal testing in monoclonal antibody development using AI models, organoid testing and real-world data to enhance safety and efficiency.

What&#39;s Going On With Charles River, Certara, Simulations Plus Stocks On Friday?

Stuttgart,,Germany,-,07-01-2023:,Person,Holding,Cellphone,With,Logo,Of

ABSI

AMRN

CBLL

FAST

NMAX

RXRX

SDGR

ZLAB

Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday

Simulations Plus Inc

Smooth Love Potion - United States Dollar

SIMPLEX HLDGS INC by SIMPLEX HLDGS INC.

Press Releases

Simulations Plus to Participate in the BTIG Digital Health Forum

Simulations Plus Announces First Quarter Fiscal Year 2025 Earnings and Conference Call Date

Simulations Plus Reports First Quarter Fiscal 2025 Financial Results

Simulations Plus Supported Development of Every FDA-Approved Drug in 2024

Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus® Enhancements

Simulations Plus to Participate in Upcoming Healthcare Investor Conferences

Simulations Plus to Present at the KeyBanc Capital Markets Virtual Healthcare Investor Forum

Simulations Plus Announces Second Quarter Fiscal Year 2025 Earnings and Conference Call Date

Simulations Plus Reports Second Quarter Fiscal 2025 Financial Results

Simulations Plus Supports New FDA Roadmap for Reducing Animal Testing in Preclinical Safety Studies

Firefly Neuroscience, Inc. - Common Stock

Firefly Neuroscience

American Well Corporation Class A Common Stock

American Well

CareCloud

Certara

Claritev Corporation Class A Common Stock

Claritev

Definitive Healthcare Corp. - Class A Common Stock

Definitive Healthcare

Doximity

DarioHealth

Evolent Health

Forian

GoodRx Holdings, Inc. - Class A Common Stock

GoodRx Holdings

Health Catalyst

HealthStream

icad

LifeMD

OptimizeRx

Phreesia

Pheton Holdings Ltd - Class A Ordinary Shares

Pheton Holdings

Schrodinger

Sophia Genetics

TruBridge

Teladoc Health

Veeva Systems

VSee Health

Waystar Holding

Keybanc

Stephens & Co.

BTIG

Craig-Hallum

Application error: a client-side exception has occurred (see the browser console for more information).